コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Mucolytic potential is widespread among intestinal bacteria.
2 the host immune system in the gut and in the intestinal bacteria.
3 atory agent cyclophosphamide (CTX) relies on intestinal bacteria.
4 enteropathy and the prevalence of pathogenic intestinal bacteria.
5 al stimulation that can functionally replace intestinal bacteria.
6 utualistic relationship between the host and intestinal bacteria.
7 uld be attenuated in the complete absence of intestinal bacteria.
8 s an exaggerated immune response directed at intestinal bacteria.
9 fense that protects against dissemination of intestinal bacteria.
10 lin or to different commensal and pathogenic intestinal bacteria.
11 on of IgM and complement-mediated control of intestinal bacteria.
12 e suggests a connection between diet and the intestinal bacteria.
13 tory IgA (SIgA) is found in association with intestinal bacteria.
14 IgT coated most intestinal bacteria.
15 gulation of the immune response to commensal intestinal bacteria.
16 tor-kappaB, are involved in the detection of intestinal bacteria.
17 s of oligosaccharides fermented by different intestinal bacteria.
20 y be due to excessive hydrogen production by intestinal bacteria altering the partial pressure of nit
22 n part, by the interaction between commensal intestinal bacteria and gut-associated lymphoid tissue (
23 cells, and the interrelationship between the intestinal bacteria and Tfh cell responses in the gut.
24 ng the complex interactions between resident intestinal bacteria and the immune system could improve
25 at host innate immune signaling can modulate intestinal bacteria and ultimately the host's susceptibi
26 ulting in tissue infiltration of 'symbiotic' intestinal bacteria and viruses that essentially become
27 of principles governing the localization of intestinal bacteria, and spatial relationships between b
29 inant daidzein metabolites produced by human intestinal bacteria are equol and O-desmethylangolensin.
34 ealed that neomycin altered the abundance of intestinal bacteria bearing gamma-d-glutamyl-meso-diamin
35 resent a major nutrient source, not just for intestinal bacteria but also for microorganisms that occ
37 matic activity leads to growth inhibition of intestinal bacteria by causing local tryptophan depletio
38 hat commensal fungi can functionally replace intestinal bacteria by conferring protection against inj
39 how a marked proportion of oxygen-sensitive intestinal bacteria can be transmitted between individua
49 t of progenitor cell responses to pathogenic intestinal bacteria could provide a measure of predispos
55 tively, these data demonstrate that resident intestinal bacteria enhance the stability of beta-cateni
57 rmfree or colonized with a limited number of intestinal bacteria failed to develop inflammatory bowel
58 d to a considerable interest in manipulating intestinal bacteria for therapeutic benefit, and trials
61 , and to microbial products derived from the intestinal bacteria, has resulted in a distinctive local
65 IgA coating uniquely identifies colitogenic intestinal bacteria in a mouse model of microbiota-drive
66 to equol and O-desmethylangolensin (ODMA) by intestinal bacteria in approximately 30-50% and 80-90% o
68 bacillus plantarum and its interactions with intestinal bacteria in mice undergoing switches between
70 microbiota, focusing on the role of resident intestinal bacteria in the development of immune respons
71 scuss the roles of known and novel commensal intestinal bacteria in the pathogenesis of inflammatory
72 Dysregulated immune responses to commensal intestinal bacteria, including Escherichia coli, contrib
73 gated whether oral inoculation with specific intestinal bacteria increased colon inflammation in the
74 sion, these results support the concept that intestinal bacteria induce endogenous signals that play
75 ring the fermentation of fiber by endogenous intestinal bacteria, induces mitochondrial function-depe
77 Our results suggest that translocation of intestinal bacteria into liver may be involved as a one
80 ses vs controls, we found that reactivity to intestinal bacteria is a normal property of the human CD
82 innate immune inflammatory response against intestinal bacteria is sufficient to induce colon cancer
86 accumulating to support the hypothesis that intestinal bacteria not only exchange resistance genes a
87 nce elicitor of systemic immune responses to intestinal bacteria observed in a loss-of-tolerance mode
89 ing of the impact of translocating commensal intestinal bacteria on mucosal-associated T cell respons
90 eview examines the influence of signals from intestinal bacteria on the homeostasis of the mammalian
91 ed that stress promotes the translocation of intestinal bacteria or their toxins into the systemic co
92 rapidly respond to commensal and pathogenic intestinal bacteria, parasites and food components by po
93 a selective force in the evolution of their intestinal bacteria, particularly by increasing the prev
95 ation after antibiotic-mediated depletion of intestinal bacteria prevents colitis and influenza, thus
98 ead to exaggerated inflammatory responses to intestinal bacteria, raising the possibility that defect
100 chain fatty acids (SCFA) are metabolites of intestinal bacteria resulting from fermentation of dieta
102 tem targets non-self rather than self, these intestinal bacteria should be considered foreign and the
103 n probiotics, nutritional components and the intestinal bacteria should be considered when examining
104 entage of them become colonized by resistant intestinal bacteria such as extended-spectrum beta-lacta
105 ns that are highly specific for target Ag on intestinal bacteria, suggesting that an aberrant T cell
106 ry bowel disease, is attributed, in part, to intestinal bacteria that may initiate and perpetuate muc
107 MIA phenotypes in offspring require maternal intestinal bacteria that promote TH17 cell differentiati
108 e contact at birth with maternal vaginal and intestinal bacteria, the authors proposed that this coul
109 s review, we explore a more sinister side of intestinal bacteria; their role as traffickers in antibi
110 New evidence has implicated the lack of intestinal bacteria to be responsible for the degradatio
111 a, which may contribute to the adaptation of intestinal bacteria to the mucosal environment in health
113 at colonization of GF mice with a variety of intestinal bacteria was capable of reducing T1D in MyD88
114 oxidative derivative of choline produced by intestinal bacteria, was positively associated with rect
115 erplay between the mucosal immune system and intestinal bacteria, we investigated the role of MIF in
117 n of SAAs from meat to sulfide production by intestinal bacteria with use of both a model culture sys
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。